Cellular therapies represent a new frontier in the treatment of neurological disease.
Mesenchymal stem cells (MSCs), which can be harvested from bone marrow, adipose tissue, and …

… Treatment and prevention of these disorders remain a … and progression of disease, failure
to diagnose diseases at … issues surrounding the treatment of neurological diseases, and …

… in the treatment of neurological diseases. … neurological diseases. Hydroxypropyl-β-cyclodextrin
received orphan drug designation for the treatment of Niemann-Pick type C disease…

… NSC Transplantation in Neurological Diseases Here, we briefly discuss the transplantation
of NSCs in certain neurological diseases and CNS injury. Parkinson's disease (PD) is …

… IVIG seems to have a favourable effect also in paraneoplastic neurological diseases (level
A), stiff‐person syndrome (level A), some acute‐demyelinating diseases and childhood …

… It is well documented that GABA deficiency is associated with several important neurological
disorders such as Huntington's chorea, Parkinson's and Alzheimer's disease and other …

… treatment option. While promising, rTMS is not yet as common in treating neurological
diseases, except for neurorehabilitation after (motor) stroke and neuropathic pain treatment. This …

… system, particularly for the treatment of neurodegenerative diseases, as well as psychiatric
… main neurological diseases and for the clinical treatment of symptoms with them correlated. …

… In this review, we discuss the role of sphingolipid mediators and their metabolizing
enzymes in neurologic diseases and putative therapeutic strategies arising thereof. …

… in the pathogenesis of neurological disease, and whether targeting HDACs may have
potential for use in treating this disease are discussed in this article and summarised in Figure 1 . …